Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Bazan

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Immunity|July 18, 2002
IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cellsStefan Pflanz, Jackie C Timans, Jeanne Cheung, et al.
Proteins|December 10, 2013
Challenging the state of the art in protein structure prediction: Highlights of experimental target structures for the 10th Critical Assessment of Techniques for Protein Structure Prediction Experiment CASP10Andriy Kryshtafovych, John Moult, Patrick Bales, et al.
Bulletin Du Cancer|October 4, 2016
[Prevalence and management of pain in patients with metastatic cancer in Franche-Comté]Fanny Dénommé, Marie Kroemer, Philippe Montcuquet, et al.
Gynecologic Oncology|October 13, 2019
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancersS Intidhar Labidi-Galy, Thibault de La Motte Rouge, Olfa Derbel, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2022
Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trialAntonio González-Martín, Christophe Desauw, Florian Heitz, et al.
JNCI Cancer Spectrum|December 14, 2024
Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe)Florence Joly, Fernando Bazan, Delphine Garbay, et al.
Proteins|October 25, 2011
Target highlights in CASP9: Experimental target structures for the critical assessment of techniques for protein structure predictionAndriy Kryshtafovych, John Moult, Sergio G Bartual, et al.
Nature Communications|December 5, 2018
Honey bee Royalactin unlocks conserved pluripotency pathway in mammalsDerrick C Wan, Stefanie L Morgan, Andrew L Spencley, et al.
Developmental Cell|October 13, 2022
Loss of non-motor kinesin KIF26A causes congenital brain malformations via dysregulated neuronal migration and axonal growth as well as apoptosisXuyu Qian, Ellen M DeGennaro, Maya Talukdar, et al.
Cell|May 14, 2011
Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathwaysLiyun Sang, Julie J Miller, Kevin C Corbit, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Immunity|July 18, 2002
IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cellsStefan Pflanz, Jackie C Timans, Jeanne Cheung, et al.
Proteins|December 10, 2013
Challenging the state of the art in protein structure prediction: Highlights of experimental target structures for the 10th Critical Assessment of Techniques for Protein Structure Prediction Experiment CASP10Andriy Kryshtafovych, John Moult, Patrick Bales, et al.
Bulletin Du Cancer|October 4, 2016
[Prevalence and management of pain in patients with metastatic cancer in Franche-Comté]Fanny Dénommé, Marie Kroemer, Philippe Montcuquet, et al.
Gynecologic Oncology|October 13, 2019
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancersS Intidhar Labidi-Galy, Thibault de La Motte Rouge, Olfa Derbel, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2022
Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trialAntonio González-Martín, Christophe Desauw, Florian Heitz, et al.
JNCI Cancer Spectrum|December 14, 2024
Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe)Florence Joly, Fernando Bazan, Delphine Garbay, et al.
Proteins|October 25, 2011
Target highlights in CASP9: Experimental target structures for the critical assessment of techniques for protein structure predictionAndriy Kryshtafovych, John Moult, Sergio G Bartual, et al.
Nature Communications|December 5, 2018
Honey bee Royalactin unlocks conserved pluripotency pathway in mammalsDerrick C Wan, Stefanie L Morgan, Andrew L Spencley, et al.
Developmental Cell|October 13, 2022
Loss of non-motor kinesin KIF26A causes congenital brain malformations via dysregulated neuronal migration and axonal growth as well as apoptosisXuyu Qian, Ellen M DeGennaro, Maya Talukdar, et al.
Cell|May 14, 2011
Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathwaysLiyun Sang, Julie J Miller, Kevin C Corbit, et al.
Pageof 11